Weekly News Round-up – 7/8/20
In the news this week, vaccine deals are afoot on either side of the Atlantic: both the U.K. and U.S. governments have signed deals with Sanofi and GSK for doses of their COVID-19 vaccine, while the UK has also requested...
4 years agoWeekly News Round-up – 7/8/20
In the news this week, vaccine deals are afoot on either side of the Atlantic: both the U.K. and U.S. governments have signed deals with Sanofi and GSK for doses of their COVID-19 vaccine, while the UK has also requested...
4 years ago
Weekly News Round-up – 17/7/20
In the news this week, despite significant alarms recently that GSK’s belantamab mafodotin could endanger patients’ eyes, the multiple myeloma drug has been approved by expert advisers. In other news, Novartis promises to make no profit from 15 of its COVID...
4 years agoWeekly News Round-up – 17/7/20
In the news this week, despite significant alarms recently that GSK’s belantamab mafodotin could endanger patients’ eyes, the multiple myeloma drug has been approved by expert advisers. In other news, Novartis promises to make no profit from 15 of its COVID...
4 years ago
Weekly News Round-up – 10/7/20
In the news this week, the Trump Administration has made another deal to acquire all initial doses of a potential COVID-19 drug, in this case Regeneron’s REGN-COV2. This follows their acquisition of the first batches of Gilead’s remdesivir last week....
4 years agoWeekly News Round-up – 10/7/20
In the news this week, the Trump Administration has made another deal to acquire all initial doses of a potential COVID-19 drug, in this case Regeneron’s REGN-COV2. This follows their acquisition of the first batches of Gilead’s remdesivir last week....
4 years ago
Weekly News Round-up – 3/7/20
Big news this week, with the U.S. administration buying up remdesivir’s stock for the next three months, ensuring no other country will receive any. In other news, Pfizer and BioNTech’s own covid drug has shown promising results in early trials,...
4 years agoWeekly News Round-up – 3/7/20
Big news this week, with the U.S. administration buying up remdesivir’s stock for the next three months, ensuring no other country will receive any. In other news, Pfizer and BioNTech’s own covid drug has shown promising results in early trials,...
4 years ago
Weekly News Round-up – 19/6/20
This week, pharma begins looking beyond the imminent struggle against Covid-19’s initial challenges to the further horizon, and the dreaded second wave. Vaccine demand in a number of countries is rising in preparation of easing lockdowns, while Gilead’s remdesivir starts...
4 years agoWeekly News Round-up – 19/6/20
This week, pharma begins looking beyond the imminent struggle against Covid-19’s initial challenges to the further horizon, and the dreaded second wave. Vaccine demand in a number of countries is rising in preparation of easing lockdowns, while Gilead’s remdesivir starts...
4 years ago
Weekly News Round-up – 5/6/20
The race for a COVID-19 vaccine continues, with AstraZeneca set to double potential capacity after a new deal struck with two companies supported by Bill and Melinda Gates. In other news, the WHO is set to restart trials for hydroxychloroquine,...
4 years agoWeekly News Round-up – 5/6/20
The race for a COVID-19 vaccine continues, with AstraZeneca set to double potential capacity after a new deal struck with two companies supported by Bill and Melinda Gates. In other news, the WHO is set to restart trials for hydroxychloroquine,...
4 years ago
Weekly News Round-up – 22/5/20
Big news this week, with AstraZeneca potentially ready to produce a Covid-19 vaccine by September this year, and Moderna receiving good news about its early-stage human trials for the same thing. In other news, the Trump administration’s new manufacturing partner...
5 years agoWeekly News Round-up – 22/5/20
Big news this week, with AstraZeneca potentially ready to produce a Covid-19 vaccine by September this year, and Moderna receiving good news about its early-stage human trials for the same thing. In other news, the Trump administration’s new manufacturing partner...
5 years ago
Weekly News Round-up – 15/5/20
In the news this week, remdesivir is authorised for emergency use in COVID-19. The drug has still not been proven to increase survival rates, but it will be vital to reduce patient recovery times. In other news, Takeda announces surprise...
5 years agoWeekly News Round-up – 15/5/20
In the news this week, remdesivir is authorised for emergency use in COVID-19. The drug has still not been proven to increase survival rates, but it will be vital to reduce patient recovery times. In other news, Takeda announces surprise...
5 years ago
Weekly News Round-up – 1/5/20
This week, Covid-19 vaccines see some advancement, with remdesivir showing strong signs of success as Pfizer prepare to put their own candidate through U.S. trials starting from next week. In other news, ‘natural killer’ cell therapies show strong potential efficacy...
5 years agoWeekly News Round-up – 1/5/20
This week, Covid-19 vaccines see some advancement, with remdesivir showing strong signs of success as Pfizer prepare to put their own candidate through U.S. trials starting from next week. In other news, ‘natural killer’ cell therapies show strong potential efficacy...
5 years ago
The Challenges of CMC in Cell and Gene Therapies
Safety is one of the most important aspects of drug development. The need for a drug to be efficacious, consistent and non-harmful to humans is vital for its success. And where a treatment is new, highly variable, and can involve...
5 years agoThe Challenges of CMC in Cell and Gene Therapies
Safety is one of the most important aspects of drug development. The need for a drug to be efficacious, consistent and non-harmful to humans is vital for its success. And where a treatment is new, highly variable, and can involve...
5 years ago